Nancy Kass

Follow

Generating author description...

All published works
Action Title Year Authors
+ PDF Chat Ethics of Adaptive Designs for Randomized Controlled Trials 2023 Gershom Chongwe
Joseph Ali
Dan K. Kaye
Charles Michelo
Nancy E. Kass
+ Towards achieving transnational research partnership equity: lessons from implementing adaptive platform trials in low- and middle-income countries 2023 Chelsea Modlin
Jeremy Sugarman
Gershom Chongwe
Nancy E. Kass
Winfred Nazziwa
Jemee Tegli
Prakriti Shrestha
Joseph Ali
+ The public’s role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States 2020 Monica Schoch‐Spana
Emily K. Brunson
Rex Long
Alexandra Ruth
Sanjana Ravi
Marc Trotochaud
Luciana Borio
Janesse Brewer
Joseph Buccina
Nancy Connell
+ Are Shorter Informed Consent Discussions, Compared with Longer Written Forms, Acceptable to Patients for Low-Risk Comparative Studies? 2020 Nancy Kass
Ruth Faden
Stephanie R. Morain
Kristina Hallez
+ Effects of a CD-ROM educational intervention (CD) on prognosis (prog) understanding among advanced cancer patients (acp) enrolling in early phase clinical trials 2004 Fay J. Hlubocky
Nancy E. Kass
Linda Fogarty
Jeremy Sugarman
Christopher K. Daugherty
+ Effects of a CD-ROM educational intervention (CD) on prognosis (prog) understanding among advanced cancer patients (acp) enrolling in early phase clinical trials 2004 Fay J. Hlubocky
Nancy E. Kass
Linda Fogarty
Jeremy Sugarman
C. K. Daugherty
+ Toward a More Comprehensive Approach to Protecting Human Subjects: The Interface of Data Safety Monitoring Boards and Institutional Review Boards in Randomized Clinical Trials 1998 V M Gordon
Jeremy Sugarman
Nancy E. Kass
Common Coauthors
Commonly Cited References
Action Title Year Authors # of times referenced
+ PDF Chat Adaptive design clinical trials: a review of the literature and ClinicalTrials.gov 2018 Laura E. Bothwell
Jerry Avorn
Nazleen F. Khan
Aaron S. Kesselheim
2
+ Equipoise and the ethics of randomization. 1995 Richard Lilford
J Jackson
1
+ The use of external monitoring committees in clinical trials of the national institute of allergy and infectious diseases 1993 Susan S. Ellenberg
Maureen Myers
William C. Blackwelder
Daniel F. Hoth
1
+ The use of response-adaptive designs in clinical trials 1993 William F. Rosenberger
John M. Lachin
1
+ PDF Chat Adaptive Clinical Trials: The Promise and the Caution 2010 Donald A. Berry
1
+ PDF Chat Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop 2012 Christopher S. Coffey
Bruce Levin
Christina Clark
Cate Timmerman
Janet Wittes
Peter R. Gilbert
Sara Harris
1
+ PDF Chat Bayesian Statistics and the Efficiency and Ethics of Clinical Trials 2004 Donald A. Berry
1
+ Adaptive Designs in Clinical Drug Development—An Executive Summary of the PhRMA Working Group 2006 Paul Gallo
Christy Chuang‐Stein
Vladimir Dragalin
Brenda Gaydos
Michael Krams
JosĂ© Cirı́aco Pinheiro
1
+ Systematic qualitative review of the literature on data monitoring committees for randomized controlled trials 2004 Matthew R. Sydes
David J. Spiegelhalter
Douglas G. Altman
Abdel B Babiker
Mahesh Parmar
1
+ A survey of monitoring practices in cancer clinical trials 1993 Stephen L. George
1
+ Monitoring versus interim analysis of clinical trials: A perspective from the pharmaceutical industry 1989 Gregory G. Enas
Bruce E. Dornseif
C. B. Sampson
Frank W. Rockhold
Julie Wuu
1
+ Practical issues in data monitoring of clinical trials: Summary of responses to a questionnaire at nih 1993 Nancy L. Geller
Mario Stylianou
1
+ Monitoring of clinical trials and interim analyses from a drug Sponsor's point of view 1993 George W. Williams
Robert L. Davis
Albert J. Getson
A. Lawrence Gould
Irving K. Hwang
Holly Matthews
Weichung Joseph Shih
Steven Snapinn
Karen Walton–Bowen
1
+ Adaptive Trials in Clinical Research 2012 Rieke van der Graaf
Kit C. B. Roes
Johannes J. M. van Delden
1
+ The Data and Safety Monitoring Board and Acquired immune deficiency syndrome (AIDS) clinical trials 1995 David L. DeMets
Thomas R. Fleming
Richard J. Whitley
James F. Childress
Susan S. Ellenberg
Mary A. Foulkes
Kenneth H. Mayer
Judith R. OÊŒFallon
Richard B. Pollard
James J. Rahal
1
+ PDF Chat Adaptive Clinical Trial Design 2014 Shein‐Chung Chow
1
+ PDF Chat Clinical trialist perspectives on the ethics of adaptive clinical trials: a mixed-methods analysis 2015 Laurie J. Legocki
William J. Meurer
Shirley Frederiksen
Roger Lewis
Valerie Durkalski
Donald A. Berry
William G. Barsan
Michael D. Fetters
1
+ Data monitoring boards in the pharmaceutical industry 1993 Jay Herson
1
+ Interim analysis in clinical trials 1991 P. Armitage
1
+ PDF Chat Are outcome-adaptive allocation trials ethical? 2015 Spencer Phillips Hey
Jonathan Kimmelman
1
+ PDF Chat Community-Centered Responses to Ebola in Urban Liberia: The View from Below 2015 Sharon Abramowitz
Kristen E. McLean
Sarah McKune
Kevin Bardosh
Mosoka Fallah
Josephine Monger
Kodjo Tehoungue
Patricia A. Omidian
1
+ Longitudinal Studies, Sequential Design, and Grant Renewals: What to Do with Preliminary Data 1979 Robert M. Veatch
1
+ PDF Chat The pragmatic clinical trial in a learning health care system 2016 Roger Lewis
1
+ Ethical issues in adaptive clinical trials 2016 Spencer Phillips Hey
1
+ PDF Chat Adaptive Clinical Trials: Advantages and Disadvantages of Various Adaptive Design Elements 2017 Edward L. Korn
Boris Freidlin
1
+ The Real‐World Ethics of Adaptive‐Design Clinical Trials 2017 Laura E. Bothwell
Aaron S. Kesselheim
1
+ PDF Chat Adaptive designs in clinical trials: why use them, and how to run and report them 2018 Philip Pallmann
Alun Bedding
Babak Choodari‐Oskooei
Munyaradzi Dimairo
Laura Flight
Lisa V. Hampson
Jane Holmes
Adrian Mander
Lang’o Odondi
Matthew R. Sydes
1
+ PDF Chat Outcome-adaptive randomization in clinical trials: issues of participant welfare and autonomy 2019 Julius Sim
1
+ PDF Chat When to keep it simple – adaptive designs are not always useful 2019 James Wason
Peter Brocklehurst
Christina Yap
1
+ PDF Chat Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols 2019 Jay Park
Ellie Siden
Michael J. Zoratti
Louis Dron
Ofir Harari
Joel Singer
Richard Lester
Kristian Thorlund
Edward J. Mills
1
+ PDF Chat A Longitudinal Study of Ebola Sequelae in Liberia 2019 Michael C. Sneller
Cavan Reilly
Moses Badio
Rachel Bishop
Allen O. Eghrari
Moses J Soka
Kumblytee Johnson
Dehkontee Gayedyu-Dennis
Lisa E. Hensley
Elizabeth S. Higgs
1
+ PDF Chat Adaptive trials, efficiency, and ethics 2019 Spencer Phillips Hey
1
+ Anti-vaccine movement could undermine efforts to end coronavirus pandemic, researchers warn 2020 Philip Ball
1
+ PDF Chat The UK hibernated pandemic influenza research portfolio: triggered for COVID-19 2020 Colin R Simpson
Ben Thomas
Kirsty Challen
Daniela De Angelis
Ellen Fragaszy
Steve Goodacre
Andrew Hayward
Wei Shen Lim
G. James Rubin
Malcolm G. Semple
1
+ Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19 2020 Nigel Stallard
Lisa V. Hampson
Norbert Benda
Werner Brannath
Thomas Burnett
Tim Friede
Peter Kimani
Franz Koenig
Johannes Krisam
Pavel Mozgunov
1
+ Data monitoring committees for multicenter clinical trials sponsored by the national institutes of health 1991 Barbara S. Hawkins
1
+ PDF Chat Global coalition to accelerate COVID-19 clinical research in resource-limited settings 2020 1